Coupang Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

August 07, 2025

Coupang (NYSE:CPNG) Second Quarter 2025 Results

Key Financial Results

Revenue: US$8.52b (up 16% from 2Q 2024).
Net income: US$32.0m (up from US$77.0m loss in 2Q 2024).
Profit margin: 0.4% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue.
EPS: US$0.018 (up from US$0.043 loss in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

earnings-and-revenue-growth — NYSE:CPNG Earnings and Revenue Growth August 7th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Coupang Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) missed analyst estimates by 71%.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Multiline Retail industry in the US.

Performance of the American Multiline Retail industry.

The company's shares are down 4.6% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Coupang, and understanding these should be part of your investment process.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

mitchell_lawler

Micron (MU) is booming, and it still doesn't look ‘expensive’ based on next year's earnings. So why does our own valuation say it could be worth 40% less?

1310

zoe_vi5fn15h

A low price to earnings ratio at the top of the cycle is a warning rather than a bargain, and a terrifyingly high one at the bottom is often the entry point

darius_xnnrd15h

Memory used to have a dozen participants racing each other into oversupply, and now it has three. High bandwidth memory is qualified into customer designs years ahead, sold under long-term agreements, and is far harder to switch away from than commodity DRAM.